Strategy

Scientist using a microscope in a laboratory setting

Our purpose

is to reimagine medicine to improve and extend people's lives.

Doctors examining a patients hand with brain scan in background

Our vision

is to become the most valued and trusted medicines company in the world.

Older adult and caregiver having a comforting conversation at home

Our strategy

is to use advanced technological approaches in research and development to ensure and expand access to modern, innovative medicines that address the greatest health burdens in society.

Therapeutic areas

We focus on therapeutic areas where there are still significant unmet needs for new treatment options.

Cardiovascular, Renal and Metabolic Diseases

In this area, Novartis focuses on diseases of the heart and blood vessels, kidneys, and metabolism, which are among the most common causes of deteriorating health and mortality in modern society. The emphasis is on early risk detection, prevention of complications, and the development of medicines for both chronic and rare diseases.

Immunology

In immunology, Novartis develops medicines for diseases in which the immune system does not function properly, such as chronic inflammatory and autoimmune diseases. The focus is on treating the underlying causes of disease, not just the symptoms. The goal is to help patients manage their condition better, with fewer flare-ups and improved quality of daily life.

Neuroscience

In the field of neuroscience, Novartis addresses diseases of the brain and nervous system that can significantly affect the lives of patients and their families. Research is focused on understanding disease progression and developing medicines that can slow or modify the course of disease. A particular emphasis is placed on improving patient independence and quality of life.

Oncology

In oncology, Novartis develops advanced medicines for the treatment of various types of cancer. The focus is on precise, targeted therapies that attack cancer cells while preserving healthy tissue as much as possible. The goal is to enable more effective treatments and better outcomes for patients at all stages of the disease.

Technology platforms

We develop and manufacture medicines on high-tech platforms that enable the development of breakthrough, innovative therapies.

Chemistry

Chemistry is the discovery of low molecular weight synthetic molecules that can be optimized as medicines.

Biotherapeutics

Biotherapeutics, or biologics, are medicines derived from the molecules of life, carefully engineered to treat specific diseases.

xRNA

RNA therapies use various forms of ribonucleic acids (RNA) to modify biological pathways in the body to treat or cure specific illnesses.

Radioligand

Radioligand therapy delivers precision-targeted radiation to cancer cells in the body with the goal of limiting damage to surrounding tissue.

Gene and cell therapy

Gene therapies modify part of a patient’s genetic makeup to help treat genetic or inherited diseases. Cell therapies treat diseases by restoring or altering certain sets of cells or by using cells to carry a therapy through the body.